Cargando…
Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects more than 24 million people worldwide and represents an immense medical, social and economic burden. While a vast array of active pharmaceutical ingredients (API) is available for the prevention and possibly treatment...
Autores principales: | Manek, Eniko, Darvas, Ferenc, Petroianu, Georg A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587961/ https://www.ncbi.nlm.nih.gov/pubmed/33096898 http://dx.doi.org/10.3390/molecules25204866 |
Ejemplares similares
-
Chitosan-based nanoparticles in Alzheimer’s disease: messenger or message?
por: Manek, Eniko, et al.
Publicado: (2021) -
Monitoring by HPLC of Chamomile Flavonoids Exposed to Rat Liver Microsomal Metabolism
por: Petroianu, Georg, et al.
Publicado: (2009) -
Chitosan Based Biodegradable Composite for Antibacterial Food Packaging Application
por: Jiang, Andre, et al.
Publicado: (2023) -
Biodegradable Chitosan Nanoparticle Coatings on Titanium for the Delivery of BMP-2
por: Poth, Nils, et al.
Publicado: (2015) -
Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model
por: Hu, Yu-Lan, et al.
Publicado: (2011)